PCRX — PACIRA PHARMACEUTICALS INC COM

Ownership history in STRS OHIO  ·  23 quarters on record

This page tracks every 13F SEC filing in which STRS OHIO reported a position in PACIRA PHARMACEUTICALS INC COM (PCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2015 Q4)
Avg. % of fund
0.0%
First filed
2011 Q2
Last filed
2025 Q3
Quarters held
23
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 4,100 — 0% 0.00% $106K $25.77
2025 Q2 ADDED 4,100 +1,100 +36.7% 0.00% $98K $23.90
2025 Q1 ADDED 3,000 +2,100 +233.3% 0.00% $75K $24.85
2024 Q3 ADDED 900 +700 +350.0% 0.00% $14K $15.05
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PCRX price (monthly, adj. close)

Other funds also holding PCRX

As of 2025 Q4 — sorted by position size

Doma Perpetual Capital Management LLC 20.21% Gagnon Advisors, LLC 3Y 7Y 4.29% GAGNON SECURITIES LLC 3Y 7Y 2.64% Bridge City Capital, LLC 3Y 7Y 2.17% Lion Point Capital, LP 3Y 7Y 1.81% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.79% Phocas Financial Corp. 3Y 7Y 0.5% EASTERLY INVESTMENT PARTNERS LLC 3Y 0.4% J. Goldman & Co LP 3Y 7Y 0.3% PDT Partners, LLC 3Y 7Y 0.28%
← Back to STRS OHIO Holdings